SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-142309
Filing Date
2019-05-09
Accepted
2019-05-09 08:16:02
Documents
3
Period of Report
2019-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d743928d8k.htm 8-K 18380
2 EX-99.1 d743928dex991.htm EX-99.1 57710
3 GRAPHIC g743928g0509030946353.jpg GRAPHIC 4598
  Complete submission text file 0001193125-19-142309.txt   83839
Mailing Address 245 FIRST STREET CAMBRIDGE MA 02142
Business Address 245 FIRST STREET CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36352 | Film No.: 19808891
SIC: 2834 Pharmaceutical Preparations